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OBJECTIVES The goal of this study was to investigate the nature of the association between silent ischemia
and postoperative myocardial infarction (PMI).
BACKGROUND Silent ischemia predicts cardiac morbidity and mortality in both ambulatory and postoperative
patients. Whether silent stress-induced ischemia is merely a marker of extensive coronary
artery disease or has a closer association with infarction has not been determined.
METHODS In 185 consecutive patients undergoing vascular surgery, we correlated ischemia duration, as
detected on a continuous 12-lead ST-trend monitoring during the period 48 h to 72 h after
surgery, with cardiac troponin-I (cTn-I) measured in the first three postoperative days and
with postoperative cardiac outcome. Postoperative myocardial infarction was defined as cTn-I
.3.1 ng/ml accompanied by either typical symptoms or new ischemic electrocardiogram
(ECG) findings.
RESULTS During 11,132 patient-hours of monitoring, 38 patients (20.5%) had 66 transient ischemic
events, all but one denoted by ST-segment depression. Twelve patients (6.5%) sustained
PMI; one of those patients died. All infarctions were non-Q-wave and were detected by a rise
in cTn-I during or immediately after prolonged, ST depression-type ischemia. The average
duration of ischemia in patients with PMI was 226 6 164 min (range: 29 to 625), compared
with 38 6 26 min (p 5 0.0000) in 26 patients with ischemia but not infarction. Peak cTn-I
strongly correlated with the longest, as well as cumulative, ischemia duration (r 5 0.83 and
r 5 0.78, respectively). Ischemic ECG changes were completely reversible in all but one
patient who had persistent new T wave inversion. All ischemic events culminating in PMI
were preceded by an increase in heart rate (D heart rate 5 32 6 15 beats/min), and most
(67%) of them began at the end of surgery and emergence from anesthesia.
CONCLUSIONS Prolonged, ST depression-type ischemia progresses to MI and is strongly associated with the
majority of cardiac complications after vascular surgery. (J Am Coll Cardiol 2001;37:
1839–45) © 2001 by the American College of Cardiology
Silent Holter-detected ischemia is associated with cardiac
morbidity and mortality both in ambulatory patients with
coronary artery disease (CAD) (1,2) and in high-risk cardiac
patients undergoing noncardiac surgery (3,4). A number of
investigators have attempted to improve cardiac outcome by
prophylactic therapy to prevent silent ambulatory or post-
operative ischemia (5–7). Nevertheless, whether silent isch-
emia is just a marker for more extensive CAD or may also
play a mechanistic role in the evolution of myocardial
infarction (MI) is debatable (8,9). The elusiveness of this
issue is at least, in part, related to the relatively low
sensitivity (37% to 50%) and specificity (88% to 92%) of
Holter monitoring in detecting myocardial ischemia (10,11)
and the relative inaccuracy of creatine kinase (CK)-MB
isoenzyme in identifying postoperative MI (PMI) (12).
Patients undergoing vascular surgery have a high preva-
lence (50% to 60%) of CAD and are at a particularly high
risk for PMI and cardiac death (5% to 15%) (13). Never-
theless, despite numerous studies that investigated almost
every predictor for PMI, its mechanisms remain poorly
understood (14,15). This study correlates data from contin-
uous perioperative 12-lead ST-segment monitoring with
serial cardiac troponin-I (cTn-I) measurements and post-
operative cardiac outcome in an attempt to obtain a better
insight into the nature of the association between postop-
erative ischemia and PMI after major vascular surgery.
PATIENTS AND METHODS
After the approval of the institutional review board and after
receiving informed consent, 185 consecutive patients under-
going major vascular surgery (84: carotid endarterectomy,
28: abdominal aortic surgery and 73: lower-extremity bypass
procedure) at the Hadassah University Hospital were stud-
ied. Patients with unstable angina or MI within the preced-
ing three months were excluded. Perioperative clinical data
were recorded prospectively. The preoperative 12-lead elec-
trocardiogram (ECG) was analyzed based on the Sokolow-
Lyon criteria for left ventricular hypertrophy (LVH) as
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previously described (16). Monitoring included continuous
intra-arterial blood pressure and pulse oximetry measure-
ment during surgery and for at least another day. Seven
patients had regional (epidural or continuous spinal) anes-
thesia; 65 had combined general and epidural anesthesia,
and 113 patients had general anesthesia only. After com-
pletion of surgery, patients were treated in the recovery
room or intensive care unit at least until the morning after
surgery. All preoperative medications were resumed post-
operatively as soon as the patients were able to take fluids by
mouth. All cardiac signs and symptoms during the hospi-
talization were recorded, and a 12-lead ECG was obtained
before hospital discharge.
Continuous 12-lead ECG recording. Before induction of
anesthesia, patients were connected to a continuous 12-lead
ECG monitor (Solar 7000, Marquette Electronics, Mil-
waukee, Wisconsin) wired through a network to a Cardiac
Review Station (ST-Guard). Each minute the ST-Guard
stored all 12-lead ECG complexes, measured the ST-
segment deviation in all leads compared with the baseline
ECG and displayed the ST trends. The ST segment was
measured 60 ms after the J point, and an episode of ST
deviation was defined as ST depression or elevation of
$0.2 mV in one lead or $0.1 mV in two contiguous leads
that lasted .10 min. Each episode of ST-segment deviation
was automatically detected and marked by the ST-Guard.
Monitoring was continued for 72 h, except in carotid
endarterectomy patients who usually ambulated after 48 h.
Treating physicians were blinded to the ST-Guard data.
However, if ischemia was clinically suspected based on other
monitors or clinical signs, physicians were allowed to
examine the changes on ST-Guard and treat those patients
accordingly. Treatment to reverse ischemia included: im-
proving oxygenation, intravenous beta-adrenergic blocking
agents (esmolol/labetalol), nitroglycerine and correction of
anemia by blood transfusion, as clinically indicated. The
12-lead ST-segment trends were reviewed by the study
investigators, and artifacts were deleted. Periods marked by
the ST-Guard as ST-segment deviations were inspected
visually for accuracy, and those reflecting artifacts or pure
up-sloping ST-segment depression were not considered as
ischemia. Each patient’s longest and cumulative ischemia
duration was recorded. Mean heart rate during the 30 min
before, at the onset of and at maximum ST deviation was
recorded from the ST-Guard.
Cardiac markers. Cardiac troponin-I and CK-MB were
measured in all patients immediately after surgery daily for
the first three postoperative days and later if clinically
indicated. Cardiac troponin-I was measured using a Stratus
II analyzer (Dade International, Deerfield, Illinois) by mass
immunoassay with two monoclonal specific antibodies.
Serum total CK and its MB isoenzyme activity were
measured by a Kodak Ektachem multiple-point rate assay
(Johnson & Johnson Co., New Brunswick, New Jersey).
Cardiac events. Cardiac death was defined as death sec-
ondary to MI, arrhythmia or congestive heart failure.
Myocardial infarction was defined as an increase in cTn-I
.3.1 ng/ml (12,17) accompanied by at least one of the
following: typical ischemic symptoms, ECG changes indic-
ative of ischemia (ST-segment depression or elevation) or
new pathological Q waves. Cardiac troponin-I .3.1 ng/ml
is also above the 99th percentile of a reference population in
our lab. This definition of MI was based on the new
consensus document formulated by the Joint American-
European Task Force for Redefinition of MI (18). All
cardiac events were assessed and agreed upon by at least two
of the investigators.
Statistical analysis. Student t test and chi-square analyses
were used to compare variables between groups of patients.
Two-tailed Pearson’s correlation coefficient was used to
correlate ischemia duration with cTn-I and CK-MB.
Receiver-operator characteristic curve (ROC) analysis was
used to assess the concordance between cTn-I and ischemia
duration and to define the cutoff values of these variables
associated with largest area under the ROC. All preopera-
tive predictors of MI with p value ,0.1 on univariate
analysis were included in a multivariate logistic regression
analysis. Forward stepwise conditional selection method
(probability criteria for stepwise: entry 5 0.05, removal 5
0.1) identified the variables independently associated with
PMI.
RESULTS
Table 1 summarizes the preoperative clinical features of all
patients and demonstrates the relatively high incidence of
CAD and cardiovascular risk factor typical to these patients.
During 11,132 patient-hours of monitoring (60.7 6 11.9
per patient), 38 patients (20.5%) had 66 ischemic episodes
(1.7 6 1.4 per patient, range: 1 to 8), all but one denoted by
ST-segment depression. One patient had an episode of
ST-segment elevation in leads L2, L3 and aVF associated
with ST-segment depression in V1 to V3 and aVL that
lasted 24 min and was not accompanied by an elevation of
cardiac markers. Table 2 depicts the characteristics of
myocardial ischemia and infarction in the 38 patients with
ischemia. The duration of the longest ischemic events was
96 6 127 min (range: 11 to 625 min), and the cumulative
ischemia duration over the entire monitoring period was
Abbreviations and Acronyms
CAD 5 coronary artery disease
CI 5 confidence interval
CK 5 creatine kinase
cTn-I 5 cardiac troponin-I
ECG 5 electrocardiogram
LVH 5 left ventricular hypertrophy
MI 5 myocardial infarction
PMI 5 postoperative myocardial infarction
ROC 5 receiver-operator characteristic curve
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150 6 252 min (range: 11 to 1,150 min). In seven patients,
myocardial ischemia was clinically suspected by the treating
physicians and their ST-Guard data were disclosed in order
to verify and treat ischemia. Four of these patients already
had prolonged ST-segment depression on the ST-Guard at
the time ischemia was clinically suspected and subsequently
had PMI.
Postoperative MI. Twelve patients (6.5%) sustained MI
(cTn-I levels: 21.1 6 26.5 ng/ml, range: 3.3 to 100.2). All
infarctions were non-Q-type. In all 12 patients, the increase
in cTn-I was detected either during (two patients) or within
18 h from a prolonged, transient ST-segment depression.
All seven clinically evident cardiac events occurred in these
patients: five patients had prolonged chest pain during peak
ischemia, one of whom died from cardiac arrest seven days
postoperatively; two patients developed congestive heart
failure during the prolonged ischemia. In the other five
patients, MI was asymptomatic. None of the 185 patients
Table 1. Preoperative Demographic and Clinical Data
All Patients
(n 5 185)
no. (%)
Patients Without MI
(n 5 173)
no. (%)
Patients With MI
(n 5 12)
no. (%)
p
Value*
Age 68 6 10 (40–92) 68 6 10 67 6 10 NS
Gender (male) 128 (69.2%) 119 (68.8%) 9 (75.0%) NS
Surgery:
CEA 84 (45.4%) 81 (46.8%) 3 (25.0%)
AAA 28 (15.1%) 27 (15.6%) 1 (3.6%)
LEBP 73 (39.5%) 65 (37.6%) 8 (66.7%) 0.13
Diabetes mellitus 53 (28.6%) 46 (26.6%) 7 (58.3%) 0.018
Hypertension 108 (58.4%) 100 (57.8%) 8 (66.7%) NS
Hyperlipidemia 73 (39.5%) 69 (39.9%) 4 (33.3%) NS
History of smoking 80 (43.2%) 74 (42.8%) 6 (50%) NS
History of IHD 79 (42.7%) 71 (41.0%) 8 (66.7%) 0.082
Previous MI 45 (24.3%) 39 (22.5%) 6 (50.0%) 0.032
Angina pectoris 38 (20.5%) 34 (19.7%) 4 (33.3%) NS
Heart failure 17 (9.2%) 14 (8.1%) 3 (25.0%) 0.049
Previous coronary
angiography
65 (35.1%) 58 (33.5%) 7 (58.3%) 0.08
Previous PTCA 27 (14.6%) 24 (13.9%) 3 (25.0%) NS
Previous CABG 33 (17.8%) 28 (16.2%) 5 (41.7%) 0.026
ECG
Q-waves 61 (33.3%) 57 (32.7%) 4 (33.3%) NS
ST depression 41 (22.2%) 36 (20.8%) 5 (41.7%) 0.092
T wave inversion 71 (38.4%) 64 (37.0%) 7 (58.3%) 0.14
LVH (voltage criteria) 30 (16.2%) 25 (14.5%) 5 (41.7%) 0.013
Medications
ACE inhibitors 59 (31.9%) 54 (31.2%) 5 (41.7%) NS
Beta-blockers 50 (27.0%) 45 (26.0%) 5 (41.7%) NS
Calcium channel blockers 62 (33.5%) 58 (33.5%) 4 (33.3%) NS
Nitrates 45 (24.3%) 41 (23.7%) 4 (33.3%) NS
Digoxin 4 (2.2%) 4 (2.3%) 0 NS
Diuretics 28 (15.1%) 24 (13.9%) 4 (33.3%) 0.06
Aspirin 112 (60.5%) 104 (60.1%) 8 (66.7%) NS
*p values for comparison between patients with and without MI.
AAA 5 abdominal aortic aneurysm repair; ACE 5 angiotensin-converting enzyme; CABG 5 coronary artery bypass
grafting surgery; CEA 5 carotid endarterectomy; ECG 5 electrocardiogram; IHD 5 ischemic heart disease; LEBP 5 lower
extremity bypass surgery; MI 5 myocardial infarction; LVH 5 left ventricular hypertrophy by voltage criteria on ECG;
PTCA 5 percutaneous transluminal coronary angioplasty.
Table 2. Perioperative Myocardial Ischemia and Infarction Details of Patients With Ischemia
All Patients
n 5 38
Patients Without MI
n 5 26
Patients With MI
n 5 12
p
Value*
Longest ischemia duration (min) 96 6 127 38 6 26 226 6 164 , 0.0001
Cumulative ischemia duration (min) 150 6 252 51 6 49 376 6 366 , 0.0001
Highest troponin-I (ng/ml) 6.9 6 17.2 0.7 6 0.9 21.1 6 26.4 , 0.0001
Highest CK-MB (IU) 60.5 6 147.9 36.1 6 110.7 115.4 6 203.9 0.14
Heart rate (beats/min)
Before ischemia 84 6 12 82 6 11 86 6 14 0.18
At onset of ischemia 106 6 18 107 6 17 104 6 19 NS
At max ischemia 116 6 18 116 6 18 115 6 19 NS
*p value for the comparison between patients with and without MI.
CK-MB 5 creative kinase-MB; MI 5 myocardial infarction.
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had new Q waves. In all patients with ischemia, including
those with infarction, the ECG changes reverted completely
to baseline, except for one patient in whom new T wave
inversion persisted for .48 h. None of the 173 patients
without MI suffered prolonged chest pain, cardiac failure or
cardiac death during the hospitalization.
Peak serum cTn-I concentration strongly correlated with
both longest ischemia and cumulative ischemia duration
(r 5 0.83, p , 0.0001 and r 5 0.78, p , 0.0001,
respectively) (Fig. 1). In contrast, maximal CK-MB corre-
lated poorly with longest or cumulative ischemia duration
(r 5 0.25 and r 5 0.19, respectively).
Cardiac troponin-I .3.5 ng/ml was associated with the
maximal area under the longest ischemia duration ROC
(Fig. 2) and close to maximal area (0.923) under the
CK-MB ROC. Similarly, longest ischemia duration of
.120 min was associated with maximal area under the
cTn-I ROC (Fig. 2).
Patients who sustained MI had more than fivefold longer
episodes of ischemia, and the cumulative ischemia duration
was more than sevenfold longer, compared with patients
with ischemia but not MI (Table 2). Of 13 patients with
longest ischemia episodes of .100 min, only two had cTn-I
levels below 3.1 ng/ml (Fig. 1), and in only one of the
patients with cTn-I .3.1 ng/ml was the longest ischemia
,100 min. Ten (83%) of the patients with infarction had
elevated CK-MB as well.
All ischemic events culminating in PMI were preceded by
an increase in heart rate. In the 38 patients with ischemia,
heart rate during the 30 min before ischemia was 84 6 12
beats/min (range: 60 to 108). It increased to 106 6 18
beats/min (range: 71 to 160, p , 0.0001) at the onset of
ischemia and to 116 6 18 beats/min (range: 82 to 162, p ,
0.0001) at the time of maximal ST-segment deviation.
Among patients with ischemia, there was no difference in
heart rate during ischemia between patients with and
without MI (Table 2). Blood pressure at onset of ischemia
in patients with MI was within their preoperative range,
except for one patient who was mildly hypotensive
(90/60 mm Hg). Five (45%) patients with MI had hemo-
globin concentration ,10 gr/dl, and, in all but one patient,
the hemoglobin concentration was lower during ischemia
than it was before surgery (D hemoglobin 5 2.9 6 1.5 gr/dl).
There was no difference, however, between patients with
and without MI in either the postoperative hemoglobin
concentration (11.3 6 1.5 gr/dl and 11.3 6 1.4 gr/dl,
respectively) or its decrement from the preoperative value
(D hemoglobin 5 1.9 6 1.3 gr/dl and 1.6 6 1.6 gr/dl,
respectively, p 5 NS).
Preoperative predictors of MI. Table 1 depicts the pre-
operative predictors of perioperative MI. By multivariate
logistic regression analysis, diabetes mellitus and LVH were
the only independent predictors of PMI (odds ratio 5 4.1,
95% confidence interval [CI] 5 1.2 to 14.4, p 5 0.027; odds
ratio 5 3.77, 95% CI 5 1.1 to 12.7, p 5 0.032, respectively).
Timing of myocardial ischemia and infarction. Twenty-
six (68%) of all the longest ischemic events started during
the period between 50 min before and 60 min after the end
of surgery, during emergence from anesthesia. In eight (67%)
of the patients with PMI, the longest ischemic episodes
started within the same time period (Fig. 3), and their
cTn-I reached .3.1 ng/ml within less than 18 h. In the
other four patients with PMI, the rise in cTn-I .3.1 ng/ml
occurred in the second and third postoperative days.
No patient had ischemia (.10 min) during induction of
anesthesia. Six patients had relatively short (#34 min)
Figure 1. Scatter plots of highest levels of troponin-I obtained during the first three postoperative days versus the longest ischemia duration recorded on
the continuous 12-lead ST-trend monitor. Lines represent the linear regression and the 95% confidence limits. r 5 Pearson’s correlation coefficient.
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intraoperative ischemia; only one of them sustained a longer
episode of postoperative ischemia, which culminated in MI.
DISCUSSION
Previous studies implied that prolonged ischemia is associ-
ated with postoperative cardiac complications. Frank et al.
(19) and Ganz et al. (20) described two patients who died
9 h and 12 h after peripheral vascular surgery, following
prolonged, silent ST depression-type ischemia on Holter
monitoring. In a study of 151 patients, the cumulative
duration of ST depression on Holter monitoring predicted
postoperative cardiac complications (4). This study expands
previous observations and shows that in vascular surgery
patients the rise in cTn-I levels signifying PMI occurs
during or immediately after prolonged, silent, stress-
induced postoperative ischemia detected on continuous
12-lead ECG.
The definition of PMI. Postoperative MI was defined as a
cTn-I level .3.1 ng/ml (12,17) after prolonged ST-
segment deviation. This definition of MI conforms to the
newly formulated European Society of Cardiology/
American College of Cardiology consensus document rede-
fining acute MI (18). Only 6 of the 12 patients with MI had
either prolonged typical chest pain (5) or persistent new T
wave inversion (1), thus fulfilling the traditional World
Health Organization criteria for MI. Our ROC analysis of
longest ischemia duration at different cutoff levels of cTn-I
further confirmed that cTn-I levels between 3 and 3.5 ng/ml
best defined PMI (Fig. 2).
Stress-induced postoperative ischemia. The majority
(67%) of ischemic events, including those culminating in
PMI, started at the end of surgery and emergence from
anesthesia (Fig. 3), a time characterized by an increase in
heart rate, blood pressure, sympathetic discharge and pro-
coagulant activity (21). This finding is supported by two
recent studies (12,22) in which the increase in troponin
occurred mostly within 12 h to 24 h after surgery and
implies that 36 h of monitoring may suffice to capture most
PMIs. Also in accordance with previous studies, ischemia
was denoted by ST depression, not elevation, and was
preceded in all cases by an increase in heart rate. In all but
one patient, ischemic ECG changes were transient, empha-
sizing the importance of continuous ST monitoring for its
detection.
Pathophysiology of PMI. The mechanism underlying
PMI is not known. It is assumed to resemble that of
nonsurgical MI (23), that is, acute plaque rupture and
coronary thrombosis caused by the abrupt increases in blood
pressure, heart rate, coronary tone and platelet aggregability
(24) and the decrease in fibrinolytic activity (25) occurring
postoperatively. However, total coronary occlusion and
coronary thrombosis are found in only 26% to 43% of
patients early after either ST elevation or ST depression–
type non-Q-wave infarction (26), compared with .90%
coronary occlusion in patients with Q-wave infarction.
None of our patients had ST elevation or Q-wave infarc-
tion. Coronary angiography was performed in only three of
our patients with PMI within seven days of the infarction,
and in each case it showed chronic, severe CAD without
angiographically visible thrombus or ruptured plaques. In
one patient the postoperative angiogram was identical to a
previous one obtained six months earlier. Is it possible,
therefore, that PMI in these patients occurred secondary to
prolonged postoperative ischemia in the presence of severe,
Figure 2. Receiver-operator characteristic (ROC) curves of (A). Longest
ischemia duration obtained at different cutoff levels of troponin-I repre-
senting myocardial infarction. (B) Highest cardiac troponin-I ROC curves
obtained at different cutoff values of longest ischemia duration signifying
myocardial infarction. AUC 5 area under the curve.
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yet stable, CAD and not as a consequence of acute coronary
occlusion?
Fuster et al. (27) proposed that, in contrast with the
common thrombotic occlusion of a coronary artery after
acute plaque disruption, thrombosis in a severe, but stable,
coronary stenosis may result from a decrease in coronary
blood flow and stasis. Tachycardia in the presence of fixed,
but severe, coronary artery stenosis is one mechanism by
which a significant decrease in coronary and myocardial
blood flow occurs due to the shortening of diastolic time
period (28). Vasoconstriction secondary to ischemia may
further decrease coronary blood flow (29,30). Hence, if
coronary thrombosis occurs in the postoperative setting, it
may be the result of and not necessarily the cause of
prolonged ischemia and PMI. Furthermore, diabetes mel-
litus and LVH were the independent preoperative predic-
tors of PMI. Both conditions are associated with reduced
coronary flow reserve and microvascular dysfunction
(31,32), and both predict increased cardiac risk. To what
extent reduced coronary flow reserve contributes to pro-
longed postoperative ischemia and PMI has yet to be
determined.
There is only limited experimental or prospective clinical
evidence for stress-induced MI. Myocardial adaptation or
hibernation, rather than deterioration to infarction occurs
after sustained (#30 min) pacing-induced ischemia and
norepinephrine infusion in animals with fixed coronary
stenosis, provided that absolute myocardial blood flow is
maintained (33). In contrast, prolonged (1 to 4 h)
tachycardia-induced ischemia in the presence of a fixed, but
critical, coronary stenosis leads to a progressive decline in
subendocardial blood flow and diffuse subendocardial ne-
crosis in anticoagulated dogs (34). One recent clinical study
(15) showed reduced PMI and cardiac death rates from 34%
to 3.4% by prophylactic bisoprolol treatment in high-risk
patients undergoing major vascular surgery. This important
report strongly supports our hypothesis that prolonged
tachycardia and stress-induced ischemia underlie the evolu-
tion of PMI and that beta-blockade, by means of preventing
prolonged postoperative ischemia, reduces PMI.
Conclusions. Although the mechanism of PMI remains
unknown, our prospective study shows for the first time a
strong temporal association between prolonged, silent, post-
operative ischemia and PMI after major vascular surgery,
suggesting that prolonged stress-induced ischemia may
progress to MI. Whether early detection and treatment of
prolonged postoperative ischemia reduce PMI has yet to be
determined. Similarly, whether prolonged stress-induced
ischemia may progress to non-Q-wave infarction in non-
surgical patients deserves further investigation.
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Figure 3. The time of onset of longest ischemia relative to the end of surgery (T 5 0). Striped bars represent the onset time of longest ischemic events
of all patients who had ischemia but no myocardial infarction; black bars represent the onset time of longest ischemic events that culminated in myocardial
infarction.
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